Introducing Colin La Galia! We’re pleased to announce that Colin has joined Epichem as its new Chief Executive Officer.
Colin brings 25 years of domestic and international pharmaceutical, diagnostics and healthcare senior executive experience to the role of CEO at Epichem and Director on the Epichem Board.
Formerly the Regional Business Director and Commercial Head of Asia Pacific, China and Japan for Abbott Rapid Diagnostics in Toxicology, Colin has also held senior leadership roles for Alere Inc, Origin Healthcare, Hollywood Fertility Centre, GlaxoSmithKline and Merck Sharpe & Dohme.
Colin has a passion for driving performance, developing people and is very proud to lead the Epichem team of dedicated professionals in delivering key outcomes in our state-of-the-art facilities in partnership with our Customers and Stakeholders.
At the same time, Dr Martine Keenan resumes her former role as Epichem’s Head of Drug Discovery and joins the Epichem board as an Executive Director.